BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11328805)

  • 1. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta -catenin nuclear signaling in breast cancer cells by modulating the intercellular stability.
    Adam L; Vadlamudi RK; McCrea P; Kumar R
    J Biol Chem; 2001 Jul; 276(30):28443-50. PubMed ID: 11328805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine phosphorylation of paxillin by heregulin-beta1: role of p38 mitogen activated protein kinase.
    Vadlamudi R; Adam L; Talukder A; Mendelsohn J; Kumar R
    Oncogene; 1999 Dec; 18(51):7253-64. PubMed ID: 10602479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase.
    Adam L; Vadlamudi R; Kondapaka SB; Chernoff J; Mendelsohn J; Kumar R
    J Biol Chem; 1998 Oct; 273(43):28238-46. PubMed ID: 9774445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.
    Miralem T; Avraham HK
    Mol Cell Biol; 2003 Jan; 23(2):579-93. PubMed ID: 12509456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M; Grijalva R; Yu D
    Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
    Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
    Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
    J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
    Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
    Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus.
    Hu P; Berkowitz P; O'Keefe EJ; Rubenstein DS
    J Invest Dermatol; 2003 Aug; 121(2):242-51. PubMed ID: 12880414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions.
    Malliri A; van Es S; Huveneers S; Collard JG
    J Biol Chem; 2004 Jul; 279(29):30092-8. PubMed ID: 15138270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.
    Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A
    Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
    Kim K; Lee KY
    Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
    Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
    J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression.
    Prieve MG; Waterman ML
    Mol Cell Biol; 1999 Jun; 19(6):4503-15. PubMed ID: 10330189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
    Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
    Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
    Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.